EasyGo
EasyGo hyaluronic acid 1.8% 1 ready-to-use syringe 2 ml
Fabre EasyGo is a medical device in injection gel form. Created on the basis of non-animal, sterile, colorless and transparent hyaluronic acid with appropriate pH indicator. Hyaluronic acid is a polysaccharide that is an important component of skin and connective tissue. The disposable 2 ml pre-filled syringe contains 1.8% (36 mg) hyaluronic acid.
EasyGo 1.8% (2 ml) pre-filled syringe also contains sodium succinate, which, in combination with hyaluronic acid, in addition to its symptomatic effect, temporarily restores the viscoelasticity of the synovial fluid and limits the processes that cause cartilage damage from injuries or degenerative causes. diseases.
How to use ?
Before administration, gently depress the plunger to remove air from the needle and pre-filled syringe to obtain a drop of product at the tip of the needle.
Application of the product should always be aseptic.
The gel should only be administered by qualified and suitably trained physicians for intra-articular injections and the preparation may only be administered intra-articularly.
Depending on the severity of the lesions, EasyGo can be applied for 3-5 weeks with a 1-2 week break between injections.
The recommended treatment regimen is 3 intra-articular injections. This application can be repeated after 6 months under the supervision of a doctor, if justified by the patient's complaints.
In case of osteoarthritis of the hip, shoulder and ankle joints, a three-injection schedule is also recommended, but there should be an interval of 1-3 months between subsequent injections.
Contents
Active ingredient: sodium hyaluronate.
Excipients: succinic acid, sodium succinate, sodium chloride, water for injection.
***Do not apply to the following people: People who are allergic to any substance in the preparation, who have received anticoagulant or thrombolytic treatment within 2 weeks, and who have symptoms of bacterial or viral infection. Do not use on people under 18 years of age. Do not use in pregnant or breastfeeding women. Do not use in areas with skin lesions (infections, reactions, etc.). Do not administer intravenously. Do not apply if the product is discolored or cloudy. Do not apply if the packaging is open or damaged. Apply the product immediately after opening and discard the pre-filled syringe. Do not use the pre-filled syringe repeatedly; regardless of the amount of product remaining after use. It is not suitable for reuse due to loss of sterility. Do not resterilize; subsequent sterilization may cause cross-contamination between patient and doctor. Do not draw air into the pre-filled syringe. Do not freeze, do not heat in a microwave oven, or apply orally. Do not use skin disinfectants containing quaternary ammonium salts such as benzalkonium chloride during application. If skin redness or swelling occurs after injection, do not cool or heat the insertion site. The product, like other injection preparations, may cause discomfort in some patients. Rash, redness, swelling, bruising, itching, and pain may occur at the injection site. In most cases, symptoms disappear within 72 hours. Do not draw air into the pre-filled syringe. Do not freeze, do not heat in a microwave oven, or apply orally. Do not use skin disinfectants containing quaternary ammonium salts such as benzalkonium chloride during application. If skin redness or swelling occurs after injection, do not cool or heat the insertion site. The product, like other injection preparations, may cause discomfort in some patients. Rash, redness, swelling, bruising, itching, and pain may occur at the injection site. In most cases, symptoms disappear within 72 hours. Do not draw air into the pre-filled syringe. Do not freeze, do not heat in a microwave oven, or apply orally. Do not use skin disinfectants containing quaternary ammonium salts such as benzalkonium chloride during application. If skin redness or swelling occurs after injection, do not cool or heat the insertion site. The product, like other injection preparations, may cause discomfort in some patients. Rash, redness, swelling, bruising, itching, and pain may occur at the injection site. In most cases, symptoms disappear within 72 hours. Do not use skin disinfectants containing quaternary ammonium salts such as benzalkonium chloride during application. If skin redness or swelling occurs after injection, do not cool or heat the insertion site. The product, like other injection preparations, may cause discomfort in some patients. Rash, redness, swelling, bruising, itching, and pain may occur at the injection site. In most cases, symptoms disappear within 72 hours. Do not use skin disinfectants containing quaternary ammonium salts such as benzalkonium chloride during application. If skin redness or swelling occurs after injection, do not cool or
